Home » J&J

J&J

Dec 06, 2017

UK Government Commits £210M to Grow Life Science Sector

The deal follows the release of a report that, among other things, urged support for genomics and other life sciences in the UK.

Feb 04, 2016

Cue Partners With J&J's Janssen Pharma on HIV Viral Load Assay

The companies will work to develop an affordable, portable, and easy-to-use HIV quantitative viral load test using Cue's Lab-In-A-Box MDx platform.

Jan 20, 2016

J&J To Cut Medical Device Jobs

Johnson & Johnson announced that it would be cutting about 3,000 jobs from its medical devices section.

Jul 15, 2015

Study Detects PD-L1 Expression on Breast Cancer Patient CTCs, Points to Potential New CellSearch Use

Premium

Using J&J's CellSearch platform, researchers have demonstrated the expression of PD-L1 on CTCs, a finding they believe they are the first to show.

May 13, 2015

Janssen Diagnostics, Biocartis Collaboration Yields Prototype HCV, Flu/RSV, Flu Surveillance Tests

Premium

Three new assays were presented in posters at April's Clinical Virology Symposium.

Apr 15, 2015

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

Jun 27, 2013

Janssen, Icahn School of Medicine to Investigate IBD

NEW YORK (GenomeWeb News) – Janssen Biotech and Johnson & Johnson Innovation today announced a research alliance with the Icahn School of Medicine at Mount Sinai to advance a better understanding of inflammatory bowel disease.

Jun 06, 2013

Startup Arcturus Pulls in $1.3M in Seed Money amid Renewed Interest in RNAi

Premium

A new firm threw its hat into the RNAi therapeutics ring this week, with San Diego startup Arcturus Therapeutics announcing that it has raised $1.3 million in seed financing to advance proprietary siRNA delivery and formulation technologies into in vivo proof-of-concept

Jun 05, 2013

Second Genome Inks Development Deal with Janssen; Raises Additional $6.5M

NEW YORK (GenomeWeb News) – Microbiome company Second Genome today announced a deal with Johnson & Johnson's Janssen Biotech aimed at microbiome drug discovery.
Second Genome also announced it raised an additional $6.5 million in Series A financing.

May 03, 2013

Australian Team Developing Plasma Protein Panel for Predicting Amyloid Burden in Alzheimer's Patients

Premium

A group of Australian researchers has identified a set of plasma proteins that could help predict patient levels of the Alzheimer's disease-associated molecule beta-amyloid.

Pages

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.